Network origin in Micah Zajic first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 57 | |
| Public Company | Biotechnology | 17 | |
MeiraGTx Ltd.
 MeiraGTx Ltd. Pharmaceuticals: MajorHealth Technology MeiraGTx Ltd. engages in the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders. The company was founded on March 20, 1991 and is headquartered in London, the United Kingdom.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
| Public Company | Biotechnology | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Micah Zajic via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| ALLOVIR, INC. | Biotechnology | President Chairman Corporate Officer/Principal General Counsel Director/Board Member Chief Tech/Sci/R&D Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Compliance Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Investor Relations Contact Corporate Officer/Principal | |
| Princeton University | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| ABEONA THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Sales & Marketing Sales & Marketing Corporate Officer/Principal | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Compliance Officer | |
| DYNE THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
| SPRINGWORKS THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| SCHOLAR ROCK HOLDING CORPORATION | Biotechnology | Chairman Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ARVINAS, INC. | Biotechnology | Director/Board Member General Counsel Corporate Officer/Principal | |
| HOLOGIC, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
| NUVALENT, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| ELOXX PHARMACEUTICALS, INC. | Biotechnology | Director of Finance/CFO Director/Board Member | |
LifeEDIT Therapeutics, Inc.
 LifeEDIT Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of ElevateBio LLC, LifeEDIT Therapeutics, Inc. is a next-generation genome editing company that has built a highly innovative platform with one of the world's largest and most diverse collections of novel RNA-guided nucleases (RGNs) and base editors. The company offers gene editing tools with higher fidelity, novel functionality, reduced immune response risk, and easier delivery. LifeEDIT has a large and diverse library of RGNs, including type II and type V systems that encompass knock-out and knock-in capabilities, transcriptional regulation, and base editing when coupled with one of their proprietary deaminases. The company's nuclease collection has a broad range of protospacer adjacent motifs (PAMs), offering unprecedented access to genomes. LifeEDIT is headquartered in Morrisville, NC. The CEO of the company is Mitchell H. Finer. LifeEDIT Therapeutics was acquired by ElevateBio LLC from AgBiome Delta LLC on October 27, 2021. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Doctorate Degree | |
| Worcester Polytechnic Institute | College/University | Chairman Undergraduate Degree | |
| University of Massachusetts | College/University | Masters Business Admin Undergraduate Degree | |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| The University of Chicago Booth School of Business | College/University | Corporate Officer/Principal Masters Business Admin | |
ElevateBio LLC
 ElevateBio LLC BiotechnologyHealth Technology ElevateBio LLC is a biotechnology holding company, which creates and operates a broad portfolio of cell and gene therapy companies. It builds single and multi-product companies by providing scientific founders with bench-to-bedside capabilities including scientists, manufacturing facilities, drug developers, and commercial expertise. The company was founded by David L. Hallal, Vikas Sinha, and Mitchell H. Finer and is headquartered in Cambridge, MA. | Biotechnology | Founder Chief Executive Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Public Communications Contact | |
| Louisiana State University | College/University | Corporate Officer/Principal Doctorate Degree | |
| Columbia Law School | College/University | Graduate Degree Graduate Degree | |
| Université Catholique de Louvain | College/University | Doctorate Degree Doctorate Degree | |
| AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Comptroller/Controller/Auditor | |
| Arradial, Inc. | Director/Board Member Corporate Officer/Principal | ||
| Boston College | College/University | Undergraduate Degree Masters Business Admin | |
| GENENTA SCIENCE S.P.A. | Pharmaceuticals: Major | Chairman Director/Board Member | |
SpringWorks Therapeutics LLC
 SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | Biotechnology | Director/Board Member Chief Executive Officer | |
| BLUEBIRD BIO, INC. | Biotechnology | Public Communications Contact Chief Tech/Sci/R&D Officer | |
VectivBio AG
 VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN. | College/University | Doctorate Degree Doctorate Degree | |
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director of Finance/CFO Public Communications Contact | |
| Stanford University | College/University | Doctorate Degree Undergraduate Degree | |
| KARYOPHARM THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Compliance Officer | |
| PDL BIOPHARMA, INC. | Biotechnology | Director/Board Member Chairman | |
| CITIGROUP INC. | Major Banks | Human Resources Officer Director/Board Member | |
| BAXALTA INC | Biotechnology | Chief Executive Officer Public Communications Contact | |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Biotechnology | Director/Board Member Sales & Marketing | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Q32 Bio, Inc.
 Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
NMD Pharma A/S
 NMD Pharma A/S BiotechnologyHealth Technology NMD Pharma ApS engages with the research and preparation of small molecules targeting an undisclosed ion. It offers medical treatment of neuromuscular diseases for patients with chronic muscle wasting diseases such as myasthenia gravis and amyotrophic lateral sclerosis. The company was founded by Ole B?kgaard Nielsen, Thomas Holm Pedersen, and Claus Elsborg Olesen on May 7, 2015 and is headquartered in Aarhus, Denmark. | Biotechnology | Chairman Director/Board Member |
Statistics
International
| United States | 47 |
| Belgium | 2 |
| Italy | 2 |
| Switzerland | 2 |
| Denmark | 2 |
Sectoral
| Health Technology | 35 |
| Consumer Services | 11 |
| Commercial Services | 3 |
| Finance | 3 |
| Consumer Non-Durables | 2 |
Operational
| Director/Board Member | 288 |
| Corporate Officer/Principal | 182 |
| Independent Dir/Board Member | 114 |
| Undergraduate Degree | 62 |
| Chairman | 58 |
Most connected contacts
| Insiders | |
|---|---|
| Stephen P. Squinto | 40 |
| Patrick Volkert Vink | 30 |
| Felix Baker | 29 |
| Max E. Link | 28 |
| William Keller | 26 |
| M. Burns | 23 |
| Christopher Coughlin | 23 |
| Sapna R. Srivastava | 22 |
| Dave Anderson | 21 |
| Zafrira Avnur | 20 |
| David Brennan | 19 |
| Bill Lundberg | 17 |
| Julie O'Neill | 16 |
| David Hallal | 15 |
| Alexis Ji | 15 |
- Stock Market
- Insiders
- Micah Zajic
- Company connections
